Home > About This Site

About PeptideLibraryHub

Our Mission

PeptideLibraryHub exists to be the most honest, well-sourced peptide education resource on the internet. In a space dominated by vendor blogs masquerading as education, influencer endorsements without citations, and marketing funnels dressed up as research guides, we believe there's a critical need for a genuinely neutral, transparent resource.

We don't sell anything. We don't link to sellers. We source from published research. When the evidence is weak, we say so. Our goal is to provide readers with the scientific foundation needed to understand peptide science, evaluate claims critically, and make informed decisions in consultation with qualified healthcare providers.

What We Cover

PeptideLibraryHub offers comprehensive, research-backed coverage of:

  • Peptide Profiles. Full mechanisms of action, clinical data, and current research status for major peptides used in clinical settings
  • GLP-1 Receptor Agonist Comparisons. Evidence-based analysis of GLP-1 drugs including approved therapeutics and investigational compounds
  • Reconstitution Guides. Technical protocols for peptide preparation from published research literature
  • Research Protocol Frameworks. Educational overview of how peptide research is structured and evaluated
  • FDA Status Tracking. Current regulatory approval status, clinical trial outcomes, and regulatory developments
  • Educational Articles. Deep-dive articles on peptide science, endocrinology, and regulatory processes

Every claim on this site links to at least one published source. Our content is designed for readers who want to understand the science, not just get quick answers.

Our Standards

Primary Sources We Use:

  • PubMed and PubMed Central (peer-reviewed biomedical literature)
  • ClinicalTrials.gov (registered clinical trial data)
  • FDA.gov (official regulatory documents and approvals)
  • Peer-reviewed journals (NEJM, JAMA, Nature, Lancet, and other high-impact publications)
  • University research institutions and publicly available research databases
  • Manufacturer investor relations and press releases (for published clinical trial data only)

Sources We Never Use:

  • Vendor marketing websites or sales-focused content
  • Affiliate marketing content or product review sites
  • Forums, Reddit, or social media discussions
  • Anecdotal reports or personal testimonials
  • Influencer content or unverified social media claims

Citation Standards:

  • Minimum 5 sources per peptide profile
  • Minimum 8 sources per GLP-1 comparison page
  • All FDA status information is date-stamped for transparency
  • When evidence is limited or contradictory, this is explicitly stated
  • All sources are clickable links to original publications

What We Don't Do

To maintain our editorial independence and educational mission:

  • We don't sell peptides, supplements, or any other products
  • We don't link to peptide vendors or suppliers
  • We don't provide personalized medical advice
  • We don't make therapeutic claims or treatment recommendations
  • We don't accept advertising or sponsored content from any commercial interest
  • We don't endorse specific products, brands, or vendors

Transparency & Independence

PeptideLibraryHub is independently maintained and operated. The site is not funded by pharmaceutical companies, peptide vendors, or advertising revenue. Content decisions are based entirely on scientific merit, educational value, and public interest, not commercial considerations.

We believe this independence is essential to our credibility. When readers visit this site, they can be confident that every decision about what to cover, how deeply to cover it, and what sources to cite is driven by the quality of the science, not by financial incentives.

Questions & Feedback

We welcome questions about our content, feedback regarding accuracy, and suggestions for topics to cover. For general inquiries, corrections, or editorial questions, please use the contact form available on the home page. We take accuracy seriously and will investigate any reported errors promptly.

Site Maintenance & Updates

This site is actively maintained and updated as new research is published, clinical trials report results, and regulatory status changes. Our FDA Status Tracker is reviewed quarterly to reflect the most current regulatory developments. New peptide profiles are added regularly as significant research or regulatory developments warrant inclusion.

Last Updated: April 2026. For the most current information on peptide research and FDA status, check back regularly or review the publication dates on individual pages and the FDA Status Tracker.